A Discussion on Value at #BIF17

In a recent op-ed, BIO President and CEO Jim Greenwood wrote about a promising trend within the health care system, one that rewards value rather than volume. As he noted, “This is the future, where there is less focus on the number of tests a patient receives and more focus on whether a patient’s health is improving.”
To ensure that future innovative cures and treatments are accessible and affordable to patients, it is incumbent upon policymakers and all stakeholders — d